EnCyzix (enclomifene)
- Region
- 🇪🇺 EU
- Active substance
- enclomifene
- Company
- Renable Pharma Limited
- Status
- Refused
- Therapeutic area
- Hypogonadism
- CHMP opinion
- Thu 25 Jan 2018
- Application
- EMEA/H/C/004198
- ATC
- G03X
- Official record
- www.ema.europa.eu
Indication
Treatment of hypogonadotropic hypogonadism in men
Regulatory milestones
No milestones recorded in the last year.
Follow EnCyzix
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.